Next Article in Journal
Identifying the Salient Genes in Microarray Data: A Novel Game Theoretic Model for the Co-Expression Network
Next Article in Special Issue
Association of Bone Mineral Density and Coronary Artery Calcification in Patients with Osteopenia and Osteoporosis
Previous Article in Journal
The Role of Fecal Calprotectin in Patients with Systemic Sclerosis and Small Intestinal Bacterial Overgrowth (SIBO)
Previous Article in Special Issue
Predictive Biomarkers and Patient Outcome in Platinum-Resistant (PLD-Treated) Ovarian Cancer
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Quantitative Multiplex Real-Time Reverse Transcriptase–Polymerase Chain Reaction with Fluorescent Probe Detection of Killer Immunoglobulin-Like Receptors, KIR2DL4/3DL3

by
Wipaporn Wongfieng
1,2,†,
Rungtiwa Nutalai
2,3,†,
Amonrat Jumnainsong
2,4 and
Chanvit Leelayuwat
2,4,*
1
Research Administration Division of Khon Kaen University, Khon Kaen 40002, Thailand
2
The Centre for Research and Development of Medical Diagnostic Laboratories (CMDL), Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen 40002, Thailand
3
Biomedical Sciences Program, Graduates School of Khon Kaen University, Khon Kaen 40002, Thailand
4
Department of Clinical Immunology and Transfusion Sciences, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen 40002, Thailand
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Diagnostics 2020, 10(8), 588; https://doi.org/10.3390/diagnostics10080588
Submission received: 23 July 2020 / Revised: 10 August 2020 / Accepted: 10 August 2020 / Published: 13 August 2020
(This article belongs to the Collection Biomarkers in Medicine)

Abstract

:
(1) Background: KIR2DL4/KIR3DL3 are the framework genes present in all KIR haplotypes, with unique expression patterns being present only in women and CD56bright NK cells. KIR genes have a high degree of DNA sequence identity. Consequently, they are one of the most challenging genes for molecular detection—especially regarding expressions; (2) Methods: We developed an effective method to determine KIR3DL3/KIR2DL4 expressions based on a multiplex quantitative real-time Reverse transcription polymerase chain reaction (qRT-PCR )with fluorescent probes using NK92; (3) Results: Standardizations of the singleplex KIR2DL4 and KIR3DL3 were performed to evaluate the sensitivity and specificity for further development of the multiplex assay. The limit of detection was at 500 copies each. There was cross-amplification with the presence of related KIR genes at a level of 5 × 107 copies. This is not biologically significant because this high level of KIR expression has not been found in clinical samples. The multiplex assay was reproducible equivalent to its singleplex (KIR2DL4; R2 = 0.995, KIR3DL3; R2 = 0.996, but lower sensitivity of 103 copies). Furthermore, the validation of the developed method on samples of blood donors showed high sensitivity (100%) and specificity (99.9%); (4) Conclusions: The developed method is reliable and highly specific suitable for evaluation of the KIR2DL4/3DL3 mRNA expressions in further applications.

1. Introduction

Natural killer cells defend at the first line of innate immunity against tumorigenic and viral infected cells. NK cells are capable of killing the major histocompatibility complex (MHC)-Class-I-deficient target cells with defective engagement of inhibitory NK cell receptors [1,2]. There are three distinct families of the inhibitory NK receptors (iNKRs) in humans: the killer-cell immunoglobulin-like receptors (KIR), the leukocyte Ig-like receptors (LILR) [3] and the lectin-like CD94: natural killer group 2 (NKG2) family [4]. KIRs (KIR—also known as CD158) are major MHC Class I receptors that contain two (KIR2D) or three (KIR3D) Ig domains called D0, D1 and D2. The cytoplasmic domain can be subdivided into either inhibitory with immunoreceptor tyrosine-based inhibitory motifs (ITIM) (KIR2DL and KIR3DL) or activating receptors (KIR2DS and KIR3DS) which have a positively charged residue within a shorter cytoplasmic tail [5,6]. The KIR-mediated regulations can significantly elicit immune responses toward cancer, viral infection, hematopoietic stem cell transplantation and pregnancy [7,8,9].
The KIR genes are tandemly located within the leukocyte receptor complex on the human chromosome 19q13.4. These genes are highly complex for three reasons: (I) allelic variations; (II) the diverse level of surface expression and (III) haplotypic diversity and gene copy number variation. Previous analyses showed that there are A and B haplotypes of the KIR gene organization. More than 50 distinct KIR haplotypes have been identified [10,11,12]. The genomic organization of KIR haplotypes contains four framework genes—KIR3DL3, 3DP1, 2DL4 and 3DL2—which are present on all human KIR haplotypes. However, the stochastic KIR expressions generate clonalities of individual’s NK cells [13]. Unlike other KIRs, the two framework KIR genes have a unique expression pattern. First, KIR2DL4 (CD158d) contains only one ITIM in the long cytoplasmic domain and a charged residue-linked adaptor molecule of FcεRI in its transmembrane region allowing this receptor to display both inhibitory and activating signals for NK cell responses. This structure is dominantly unique among the KIR family members. However, the mechanism that controls KIR2DL4 to elicit activating or inhibitory signals yet remains unclear. During early stage of pregnancy, NK cells that are a majority of lymphocytes comprising in the fetal-maternal interface, play an important role for successful implantation. Indeed, KIR2DL4 is one of the dominant receptors in uterine and decidual NK cells modulating pregnancy circumstances [14]. Its ligand, HLA-G, is expressed by the fetal trophoblast [15], by tumor cells [16] and by thymic epithelial cells [17]. Interestingly, the transcriptional level of KIR2DL4 significantly decreases with increased risk for pre-eclampsia [13,14]. Moreover, the KIR2DL4 surface expression on the uterine NK cells is expressed at a statistically higher level in a recurrent spontaneous abortion than normal controls. Second, KIR3DL3 shows structural protein divergence away from other KIR3DL, with a deletion of the stem region and possesses one ITIM in its truncated cytoplasmic tail (as does KIR2DL4) [5,18]. An unusual feature of KIR3DL3 is that the mRNA level is restricted and only expressed in the decidual NK and CD56bright NK cells. However, the protein expression is absent. Moreover, women’s PBMCs tend to highly express the mRNA levels compared to those of men [19]. The role of KIR3DL3 in pregnancy involving immune responsive NK cells is not yet clear. The expression pattern of KIR3DL3 is not well examined because mRNA transcript is very difficult to detect in the total RNA from human peripheral blood mononuclear cells (PBMCs). In addition, the high degree of sequence similarities among KIRs makes them difficult to specifically be detected. To elucidate the function of these two KIR genes, it is essential to specifically detect their patterns of expressions in various cell types. The purpose of this study was to set up the quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) with fluorescent probe assay to carry out the KIR2DL4/3DL3 mRNA detections. Novel probes specific for KIR2DL4/3DL3 mRNAs have been developed. The novel method could simultaneously and comparably determine the expressions of KIR2DL4/3DL3 in a single tube of a sample using a new reference gene, RPII. The method has been verified for sensitivity, specificity, limit of detection and cross-reactivity as well as validated on human samples. The developed multiplex real-time RT-PCR with the fluorescent probe assay could reliably differentiate biologic mRNA expression levels of KIR2DL4 and 3DL3 in a single tube.

2. Materials and Methods

2.1. Sequence Analyses and Probe Design

All alleles of 17 KIR gene sequences were retrieved from the IPD-KIR Database [20]. Nucleotide sequences were multiple aligned and analyzed by Clustal Omega [21] which only one sequence was used to be a representative for all alleles of each KIR; 2DL1*001 (L41267.1), 2DL2*0010101(U24075.1), 2DL3*0010101(L41268.1), 2DL4*00101(X99480.1), 2DL5A*0010101(AF204903.1), 2DS1*001(X89892.1), 2DS2*0010101(L41347.1), 2DS3*00,101(L76670.1), 2DS4*0010101(U24077.1), 2DS5*001(L76672.1), 3DL1*0010101(U30274.1), 3DL2*0010101(L41270.1), 3DL3*00,101(AJ938052.1), 3DS1*010(L76661.1). The numbers of alleles for each KIR gene were represented in Table S1. All 109 alleles of KIR2DL4 and 166 alleles of KIR3DL3 were analyzed by BioEdit to design highly specific probes that could not cross-react to all alleles of other KIRs. All primers for KIR gene amplifications were used as described by Tajik el al., 2009 [22]. Whereas RNA polymerase II (RPII) sequences were retrieved from the NCBI Database and were used to design primers and probe to amplify the mRNA transcript at the exon 26–27, as a reference gene for normalization. Primer and probe sequences used in this study were given in Table 1.

2.2. Reverse Transcription, Polymerase Chain Reaction and Plasmid Constructs

The total RNA of NK92 was prepared by the TRIzol extraction (Invitrogen, Carlsbad, CA, USA) and consecutively conversed to cDNA by using the Moloney murine leukemia virus reverse transcriptase (M-MLV RT) (Promega, Madison, WI, USA) according to the manufacturer’s instructions. To generate plasmids of KIR2DL4, KIR3DL1, KIR3DL3 and RPII, amplifications of segmented cDNA with specific primers (Table 1) were performed by the PCR assay. Each 25-µL reaction contained 500 ng of cDNA of NK92, 0.2 mM dNTP, 1X PCR buffer, 2 mM MgCl2, 0.3 µM of primers and 5 units of Taq DNA polymerase. The amplification cycles were; denaturation for 5 min at 95 °C, then 30 cycles of 30 s at 95 °C, 30 s at 60 °C and 30 s at 72 °C followed by 72 °C for 10 min. The PCR products purified by the illustra™ gel band purification kit (GE Healthcare, Chicago, IL, USA) were cloned into the pGem®T easy vector system (Promega, Madison, WI, USA) according to the manufacturer’s instructions and then transformed into the E. coli XL-1 blue cells (Stratagene, La Jolla, CA, USA). Positive clones were selected by ampicillin resistant-positive and blue-white colony selection and confirmed by DNA sequencing (Macrogen, Inc., Seoul, Korea).
The DNA plasmid constructs were calculated for the number of copies as shown below and subsequently prepared for a serial dilution to set up standard curves. Ten-fold dilution series of the plasmid constructs were prepared in sterile distilled water (DW), yielding 8 concentrations ranging from 101 to 108 copies/reaction. The calculation formula for number of copies is as follow [23]:
Number of copies/µL = Plasmid concentrations (g/µL) × 6.022 × 1023
(molecules/mole)
            (Length of DNA fragment) bp (× 660) Daltons

2.3. Optimization of Real Time Quantitative PCR (qRT–PCR)

Optimal conditions of conventional PCR to amplify fragments of KIR2DL4, 3DL3 and RPII were performed with the cDNA of NK92 using an VeritiTM 96-well fast thermal cycler (Applied Biosystems, Waltham, MA, USA). Thermal cycles were set as follows: one cycle of 5 min at 95 °C, 30 cycles of 30 s at 95 °C, 30 s at 58 °C and 30 s at 72 °C, followed by a 5 min final extension at 72 °C.
Real-time PCR, using the AccuPower® Plus DualStarTM qPCR PreMix MasterMix (Bioneer, Daejeon, South Korea), was optimized using different annealing temperatures based on the end-point PCR and performed by using the ExicyclerTM 96 machine. Each 50-µL reaction contained 25 µL 2× AccuPower® Plus DualStarTM qPCR PreMix MasterMix, primers and probes at a concentration of 0.4 µM, 1× of 50× ROX dye and 5 µL of 108 copies/µL of plasmid–KIR2DL4, -KIR3DL3 and -RPII. The cycling conditions were an initial first cycle of 5 min at 95 °C, followed by 45 cycles consisting of first 20 seconds at 95 °C and then 45 s at 56.11, 57.78 and 60 °C. An auto-base lining default was used to show the Ct values. Multiplex PCR reactions were also carried out and the PCR amplification conditions were the same as that of the singleplex assay (annealing temperature at 58 °C).

2.4. Sensitivity and Reproducibility

Singleplex real-time PCR assays were carried out prior to multiplexing for all the three primer pairs to evaluate their sensitivity and specificity. For KIR2DL4, 3DL3 and RPII, serial ten-fold dilutions of plasmid constructs 101 to 108 copies/µL were tested according to the previous protocol. The cycling conditions were 95 °C for 5 min, followed by 95 °C for 20 s and 58 °C for 45 s, for 45 cycles and then, run in triplicates of 6 times for the between run assays. The different plasmid concentrations (copies) were plotted against the corresponding Ct values. The method efficiencies were calculated according to E = (10(−1/Slope) − 1) × 100%.
An irrelevant DNA sequence cloned into the pGemT plasmid in the concentration at 108 copies/µL was simultaneously tested in duplicate with at least six independent experiments for KIR2DL4, KIR3DL3 and RPII. Mean Ct value and standard deviation were calculated and the limit of detection (LOD) was determined, accordingly. Sensitivity of the multiplex was obtained by using the serial dilutions of three plasmid constructs from KIR2DL4, KIR3DL3 and RPII. Mixed three templates of 102 to 106 copies of KIR2DL4 and KIR3DL3 were simultaneously evaluated along with the baseline levels of RPII at 102 and 103 copies in triplicates of 6 times. The mean Ct value for each dilution was compared between the singleplex and multiplex assays.

2.5. Specificity

In cross-reaction assessment, the set of primers and probe of KIR2DL4 was tested with KIR3DL1, KIR3DL3 and RPII plasmids while the set of KIR3DL3 was tested with the KIR3DL1, KIR2DL4 and RPII plasmids in the concentrations at 5 × 106 to 5 × 108 copies per reaction. Moreover, primers and probes of RPII were tested with the KIR2DL4, KIR3DL1 and KIR3DL3 plasmids, accordingly. The data were obtained from duplicates and representatives of three independent experiments.

2.6. Human Sample Collection and RNA Extraction

One hundred whole blood samples of healthy donors were received from the blood bank center at Srinagarind Hospital of Khon Kaen University under ethical approval of the Khon Kaen University, Ethics in Human Research Committee (HE621256). To separate the buffy coat, the whole blood samples were centrifuged at 3500 rpm for 10 min at 4 °C and then discarded the serum and collected only the buffy coat. Total RNA were extracted from each buffy coat of a blood sample by The Pure LinkTM RNA Mini Kit (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s instructions, then 500 ng of RNAs were consecutively conversed to cDNA with the Moloney murine leukemia virus reverse transcriptase (M-MLV RT) kit (Promega, Madison, WI, USA) using an Veriti™ 96-well fast thermal cycler (Applied Biosystems, Waltham, MA, USA).

2.7. Sensitivity and Specificity in Human Samples

The human cDNA samples were tested with the singleplex and the multiplex qRT-PCR as described above. Then the expression values of KIR2DL4, KIR3DL3 and RPII reference gene were analyzed by ROC analysis, we used the limit of detection (LOD) as a cutoff at 102 copies for the singleplex RT-PCR and 103 copies for the multiplex RT-PCR to select the best sensitivity and specificity.

2.8. Statistical Analysis

Quantitative data were presented as mean ± standard deviation (X ± SD). The equation of linear regression and linear correlation coefficient (R2) was determined with the GraphPad Prism software version 5.0 for Windows (GraphPad Software, San Diego, CA, USA). The receiver-operating characteristic (ROC) curves, specificity, sensitivity and Youden’s index (YI), were analyzed by SPSS version 16 (SPSS, Inc., Chicago, IL, USA). Positive likelihood ratio (+LR), negative likelihood ratio (−LR) and were analyzed by the GraphPad Prism software version 5.0.

3. Results

3.1. Sequence Analysis and Probe Design

From the IPD database, the KIR sequences were highly polymorphic representing several alleles from each locus ranging from 16 to 184 alleles (Table S1). There were 109 and 166 alleles, respectively, for KIR2DL4 and KIR3DL3. The mRNA sequences of all KIRs were compared using the Clustal Omega program. The percentages of sequence identities are shown in Table S2. They were so similar ranging from 70.69%–96.94%. Thus, it would be difficult to design specific primers that amplify all alleles of each locus and discriminate those of other loci. Consequently, specific probes were designed to improve specificity and the primers were used as described by Tajik el al., 2009 [22]. KIR2DL4 was closely related to KIR2DL5A and shared homology of 88.12%. They were type II KIR2D encoding two extracellular domains with D0 and D2. Likewise, KIR3DL3 was highly similar to the KIR3D genes (87.43% homology to KIR3DL2). KIR2DL4, which also possesses two immunoglobulin-like domains, shares sequence similarities to KIR3DL1 and KIR3DL3 with 75.02% and 72.63%, respectively. Expectedly, KIR3DL3 was more similar to KIR3DL1 at 86.70% identity as shown in Table S2.
Specific probes were designed to hybridize within the region between the primers avoiding complementary with other KIR sequences and either primer sequences (Figure S1). Probes should not contain a G nucleotide at their 5′ ends due to an arrangement of quencher reporter fluorescence after cleavage from the 5′-exonuclease activity of the Taq enzyme. High specificity and effective probes should be able to detect all alleles of target KIR genes and differentiate from other KIR genes.

3.2. Optimization of Annealing Temperature for qRT-PCR

The amplicon PCR products of targeted KIR genes and reference control were amplified from the cDNA of NK92 with specific primers. Amplification products of KIR2DL4, KIR3DL3 and RPII were approximately 130, 199 and 143 bp, respectively (Figure S2). Further development to determine an optimal annealing temperature among these primers and probes was conducted at 56.11, 57.78 and 60 °C (see “Materials and methods”). We selected the high efficiency of amplification based upon the threshold cycle time (Ct) and the high intensity of signal for all tests. Thus, the annealing temperature at 58 °C was used which was the same as that used in the end-point PCR (Figure S3).

3.3. Assessment of Sensitivity and Reproducibility for Singleplex qRT-PCR

Serial dilutions with varying copy number of standard plasmids generated previously were used to determine the sensitivity and variability of the method. The cycle time (Ct) represented the amount of template present at the beginning of the reaction. The standard curve based on the serial dilutions of KIR2DL4, KIR3DL3 and RPII clones showed a linear relationship between log copy number and mean of the threshold cycle time (Ct) (Figure 1 and Table S3). The results obtained from qRT-PCR were significantly high precision or less variable. From the between run experiments, percentages of coefficient of variation (% CV) of all assays were less than 7% even when % CV values of within run and between run should ideally be less than 10% and 15%, respectively. Mean of cycle time (Ct), standard deviation (SD) and percentage of coefficient of variation (% CV) were calculated for each level and were given in Table S3. However, the reproducibility at low copy number was not so reliable. To determine the limit of detection (LOD), irrelevant sequences were evaluated. The threshold cycle times of irrelevant sequences were overlapping with the standard target template at 50 copies for KIR3DL3 and at less than 50 copies for the KIR2DL4 and RPII assays (Figure 1A,C,E). Thus, the LOD of KIR3DL3 was at 500 copies, but LOD of KIR2DL4 and RPII were at 50 copies. The standard curves were generated to show the sensitivity of these assays with the linear regression equation, a square regression coefficient (R2) and amplification efficiency (E) (Figure 1B,D,F). In theory, correlation coefficient (R2) for a detection assay should be >0.98 and efficiencies (E) range from 90% to 110%. The linearity of standard curves of KIR2DL4 and RPII presented the lower detection limit at 500 copies because detection assay became less reliable at a lower template concentration of 50 copies per reaction. Therefore, the qRT-PCR assays for KIR2DL4, KIR3DL3 and the reference gene RPII had the limit of detection (LOD) at 500 copies. Comparing to the conventional end-point RT-PCR, the detections of KIR2DL4 and KIR3DL3 by the developed method were 10 times more sensitive. The conventional method had the detection limit at 103 copies (Figure S4A,B). In addition, the qRT-PCR detection of RPII was 1000 times more sensitive than the conventional method with a lower detection limit at 105 copies (Figure S4C).

3.4. Assessment of Specificity for Singleplex qRT-PCR

To evaluate the specificity, a combination of both specific primers and/probe was tested against the reference RPII gene, the irrelevant sequence clones and the related non-target KIR sequences. In the cross-reaction experiments, the KIR2DL4 and KIR3DL3 detection assays could positively cross-react with the related-KIR genes. This was noted only when the non-target KIRs were present at a level of more than or equal to 5 × 107 copies (Figure 1A,C and Table S3). This very high level of cross-reactivity is insignificant because normally the KIR expressions would be less than 105 copies [24]. In contrast, the RPII detection assay was specific and did not cross-react with KIR2DL4, KIR3DL1 and KIR3DL3 (Figure 1E and Table S3).

3.5. Development of Multiplex qRT-PCR

The performance of multiplex qRT-PCR was compared to the singleplex assay. Following limit of detection and specificity of the singleplex, the analytical sensitivity of multiplex real-time PCR was determined on mixtures of serial dilutions between the lower and upper limit of detections (102–106 copies) for KIR2DL4 and KIR3DL3 with 102 and 103 copies of the reference gene. The assays were evaluated in triplicate using multiplex conditions as outlined in the Materials and Methods. A competitive amplification was found when 105 and 106 template copies of KIR2DL4/3DL3 were determined with the RPII gene at 102 copies, resulting in no signal of RPII. The same results were obtained, although the RPII primer and probe concentrations in the reactions were increased to 0.4 and 0.8 µM (Table S4). A limiting assay was performed to determine at which 103 copies of RPII in the multiplex was efficiently amplified with a correlated Ct in the singleplex (Table S4). In accordance with this evaluation, there was a strong linear regression coefficient of KIR2DL4 and KIR3DL3 (R2 = 0.996 and 0.999, respectively) which was similar to the single step assays (Figure 1B,D). Compared to the singleplex real-time PCR, the multiplex real-time PCR for KIR2DL4/3DL3 including the reference gene were less sensitive (LOD = 103 copies). A strong correlation between the singleplex and multiplex qRT-PCR detections was found for all: KIR2DL4 (R2 = 0.995), KIR3DL3 (R2 = 0.996) (Figure 2A,B). The correlations were effectively linearity when R2 was higher than 0.99.

3.6. Detection of KIR Gene Expression in Human Samples

To validate whether the method is applicable to human samples, an ROC analysis was performed on samples of blood donors. One hundred blood samples of healthy donors with ethical approval (HE621256) were used to study. First, each blood sample was extracted for total RNA, next converted into cDNA and then analyzed for KIR2DL4, KIR3DL3 and RPII expressions by the multiplex RT-PCR. The median expressions of KIR2DL4 and KIR3DL3 were at 1.4 × 104 (40.67–1 × 105) and 1.9 × 104 (51.45–1.7 × 106) copies, respectively. (Figure S5). In ROC analysis, we used the limit of detection (LOD) at 102 copies for the singleplex RT-PCR and 103 copies for the multiplex RT-PCR as a cutoff. The expressions of KIR2DL4 and KIR3DL3 as well as ROC curves were presented in Table 2 and Figure 3. Observing the area under the ROC curve of the three genes by multiplex assay, KIR2DL4 and KIR3DL3 gave the highest score at 0.998 and followed by RPII with the score at 0.984. The sensitivity and specificity of the multiplex qRT-PCR in healthy donors were calculated with 100% and 99.97%, respectively, for KIR2DL4 and KIR3DL3, but the specificity of RPII was 99.85%. For the singleplex assay, the area under the ROC curve of KIR2DL4 gave the highest score at 0.984 and followed by KIR3DL3 and RPII with score 0.968 and 0.952, respectively. The sensitivity and specificity of the singleplex qRT-PCR in healthy donors were calculated with 100% and 99.96%, respectively, for KIR2DL4 and KIR3DL3, but the specificity of RPII was 99.88%. The results indicated that the determination of KIR2DL4, KIR3DL3 and RPII expressions in 100 healthy donors by using the developed method had high sensitivity and specificity of both multiplex and singleplex RT-PCR assays. These were consistent with the study using the standard target templates.
Further assessment was demonstrated by the best score of sensitivity, specificity and Youden’s index. The positive likelihood ratio (+LR) was used to indicate the probability for a correct analysis of a method. Usually, a number greater than one or a number that near 10 is indicated as an excellently appropriate method. In contrast, the negative likelihood ratio (−LR) was used to indicate the possibility of incorrect analysis of a method. The lower value indicated optimal, usually less than one. The study demonstrated that, for all 3 genes, the KIR2DL4 and KIR3DL3 had the best sensitivity, specificity, LRs and YI (Table 3). These results supported the above data which indicated that the developed method had high sensitivity and specificity.

4. Discussion

In this study, we successfully set up a quantitative multiplex real-time RT–PCR with fluorescent probes for reproducible detection of the KIR2DL4 and KIR3DL3 transcripts. This technique was carefully developed and designed to maximize the sensitivity and specificity. Although the genomic detection of KIRs has been reported [25], few studies had determined KIR expressions by a real-time PCR without the verification and characterization of their assays [19,24]. Validation is the critical evaluation of an assay’s performance for the high-homolog KIR gene family. Moreover, normalization was performed to avoid variations in different tissue samples or various cell types by establishment of a stable reference gene, RPII [26]. KIR2DL4 expression has been reported to be expressed in all human NK cells and on all KIR haplotypes [18,27]. In contrast, the transcripts of KIR3DL3 were more specific to the subset of CD56bright NK cells, especially in women’s peripheral blood and decidual NK cells, though, they are the framework genes in all KIR haplotypes [19]. The strong sequence conservation of KIR2DL4 and KIR3DL3 genes among many primates suggests that these genes serve a function [28]. Previous research has determined allelic variation of KIR2DL4 affecting the mRNA level and cell surface expression [29]. Using end-point PCR, the KIR2DL4 transcripts have been reported to be increased by the IL-2 activation [30] and some specific conditions [31]. Moreover, the HLA-G ligand could induce upregulation of the KIR2DL4 mRNA. In contrast, KIR3DL3 was poorly investigated for mRNA expressions due to a technical difficulty. IL-2 cytokine stimulations failed to induce KIR3DL3 expression [32].
Extensive sequence identities of KIRs make them so difficult to establish a molecular method specific to a particular KIR gene expression [33]. The KIR3DL3 expressions were detected only after the 2nd round of RT-PCR and some samples were not detectable even after the 2nd round due to the very low level of KIR3DL3 [19]. It is possible that the KIR mRNA levels are so diverse. Thus, a difficulty in amplifying KIR transcripts may affect the detection of mRNA in samples resulting in variable data on expressions of KIR2DL4/3DL3. Specific primers with specific probes enable specific detections of KIR2DL4/3DL3 and differentiate from the others increasing the specificity and sensitivity of detections. We have shown that the sensitivities were improved by 10–1000 times.
The accuracy of absolute quantification depends on the accuracy of the standards. The standards of KIR2DL4/3DL3 and the RPII reference gene were shown to be reliable with a high value of square regression coefficient (R2). For the singleplex, the amplification was effective with the sensitivity defined by the limit of detection at 500 copies per reaction. The cross reactivity was detected in the KIR3DL3 detection when the KIR2DL4 and KIR3DL1 were present at the same level as the study of Brooks CR et al. [24], which showed cross reactivity of KIR2DL1 against nonspecific KIR2DL3 at a level of 5 × 107 copies. It was difficult to find the KIR transcripts up to the level of 5 × 107 copies per reaction in clinical samples. Whereas the developed multiplex qRT–PCR, was reproducible indicated by the high correlation coefficient (R2 > 0.99) and showed the limit of detection at 103 copies which should potentially be sensitive enough for biologic detections.
The copy numbers of KIR2DL4 and KIR3DL3 mRNA expressions in samples could be calculated from the slope of linear regression of the standard curve. Target Ct values were directly compared to an internal reference Ct (RPII) and the data were presented as relative expression of the specific mRNA-targets to the internal reference gene. Changes of KIR expression levels are significantly related to biologic function on NK cells; therefore, the variable expression of internal reference expression affects the accuracy calculation of quantitative RNA analysis. The amplification efficiencies of the internal reference must be similar to the targeted gene. RNA polymerase II was selected to be an internal reference gene in this study because it has been reported to be consistently expressed in almost all cells and tissues. Moreover, RPII is a crucial enzyme in mRNA transcription and it constantly expresses under the activation experiment [26]. For gene studies, lower-level expression of RPII compared to the usual reference gene GAPDH, allows the normalization of slightly differences in the amount between the two targeted genes leading to higher sensitivity.
The validated performance of the developed method on human samples by the singleplex and the multiplex RT-PCR showed that both the multiplex and singleplex methods gave the same high value of sensitivity, specificity and AUC. Moreover, the results of these methods showed that both KIR2DL4 and KIR3DL3 were so diversely expressed and the highest expression were 1 × 105 and 1.7 × 106 copies, respectively. Furthermore, KIR3DL3 mRNA level was higher in female than in male samples but were not statistically significant (median of male = 3.4 × 104 range 51.45–1.4 × 105 copies, median of female = 3.67 × 104 range 50.21–1.7 × 106 copies). This was similar to the study of Trundley AE et al. [19]. Additionally, KIR2DL4 and KIR3DL3 were higher in donor samples who were older than 34 years but were not statistically significant. To confirm this result, a larger sample size would be required. The ROC analysis of these samples indicated that the method could be applicable on human samples and was consistent with the standard target templates tested.

5. Conclusions

In conclusion, we developed quantitative and specific detections of KIR2DL4 and KIR3DL3 expressions based on a multiplex qRT-PCR with fluorescent probe assay. The method was validated using human samples, establishing that the method is applicable to human samples. KIR transcriptional levels related to surface protein expressions could control the definite NK functions. This method may aid in determining the physiological and pathologic conditions that KIR2DL4 and KIR3DL3 could be expressed on NK cells and subset of NK cells especially in the decidual NK cells.

Supplementary Materials

The following are available online at https://www.mdpi.com/2075-4418/10/8/588/s1, Figure S1: Comparative multiple-sequence alignments of primer and probe sequences, Figure S2: Amplification of segmented cDNA of KIR2DL4, KIR3DL3 and RPII by RT-PCR assay, Figure S3: Optimization with varying annealing temperature for qRT-PCR, Figure S4: Sensitivity of conventional end-point PCR assay for the serial dilutions of standard plasmid DNA, Figure S5: KIRs gene expression on clinical samples, Table S1: Total number of alleles of 17 KIR genes, Table S2: Reproducibility assessment of reference gene in multiplex assays, Table S3: The reproducibility and cross reactivity assessment, Table S4: Reproducibility assessment of reference gene in multiplex assays.

Author Contributions

R.N., W.W., A.J. and C.L. designed and planned the study; R.N. and W.W. executed and analyzed the experiments; R.N., W.W., A.J. and C.L. critically discussed; R.N. and W.W. wrote the first draft of the manuscript; C.L. finalized the manuscript; C.L. supervised the entire project. All authors have read and agreed to the published version of the manuscript.

Funding

W.W. was supported by a scholarship under the postdoctoral training program (PD2562-08) from Khon Kaen University, Thailand. R.N. is holding a scholarship supported by the Royal Golden Jubilee Ph.D. program (RGJ) (RGJ:PHD/0040/2556), Thailand Research Fund (TRF). The funding sponsors had no role in the design of the study, in the analyses or the interpretation of data; in the writing of the manuscript and in the decision to publish the results.

Acknowledgments

We thank Ashley Moffett for providing the NK92 cell line. This work was supported by the Center for Research and Development of Medical Diagnostic Laboratories (CMDL) and RGJ.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Kärre, K.; Ljunggren, H.-G.; Piontek, G.; Kiessling, R. Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 1986, 319, 675–678. [Google Scholar] [CrossRef] [PubMed]
  2. Algarra, I.; Cabrera, T.; Garrido, F. The HLA crossroad in tumor immunology. Hum. Immunol. 2000, 61, 65–73. [Google Scholar] [CrossRef] [Green Version]
  3. Martin, A.M.; Kulski, J.; Witt, C.; Pontarotti, P.; Christiansen, F. Leukocyte Ig-like receptor complex (LRC) in mice and men. Trends Immunol. 2002, 23, 81–88. [Google Scholar] [CrossRef]
  4. Lazetic, S.; Chang, C.; Houchins, J.P.; Lanier, L.L.; Phillips, J.H. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J. Immunol. 1996, 157, 4741–4745. [Google Scholar]
  5. Vilches, C.; Parham, P. KIR: Diverse, Rapidly Evolving Receptors of Innate and Adaptive Immunity. Annu. Rev. Immunol. 2002, 20, 217–251. [Google Scholar] [CrossRef]
  6. Macfarlane, A.; Campbell, K.S. Signal Transduction in Natural Killer Cells. Curr. Top. Microbiol. Immunol. 2006, 298, 23–57. [Google Scholar]
  7. Hiby, S.E.; Walker, J.J.; O’Shaughnessy, K.M.; Redman, C.W.; Carrington, M.; Trowsdale, J.; Moffett, A. Combinations of Maternal KIR and Fetal HLA-C Genes Influence the Risk of Preeclampsia and Reproductive Success. J. Exp. Med. 2004, 200, 957–965. [Google Scholar] [CrossRef]
  8. Ruggeri, L.; Capanni, M.; Urbani, E.; Perruccio, K.; Shlomchik, W.D.; Tosti, A.; Posati, S.; Rogaia, D.; Frassoni, F.; Aversa, F.; et al. Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants. Science 2002, 295, 2097–2100. [Google Scholar] [CrossRef] [Green Version]
  9. Khakoo, I.S.; Thio, L.C.; Martin, P.M.; Brooks, R.C.; Gao, X.; Astemborski, J.; Cheng, J.; Goedert, J.J.; Vlahov, D.; Hilgartner, M.; et al. HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection. Science 2004, 305, 872–874. [Google Scholar] [CrossRef]
  10. Hsu, K.C.; Liu, X.-R.; Selvakumar, A.; Mickelson, E.; O’Reilly, R.J.; Dupont, B. Killer Ig-like receptor haplotype analysis by gene content: Evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J. Immunol. 2002, 169, 5118–5129. [Google Scholar] [CrossRef]
  11. Chaisri, S.; Kitcharoen, K.; Romphruk, A.V.; Romphruk, A.; Witt, C.S.; Leelayuwat, C. Polymorphisms of killer immunoglobulin-like receptors (KIRs) and HLA ligands in northeastern Thais. Immunogenetics 2013, 65, 645–653. [Google Scholar] [CrossRef] [PubMed]
  12. Chaisri, S.; A Traherne, J.; Jayaraman, J.; Romphruk, A.; Trowsdale, J.; Leelayuwat, C. Novel KIR genotypes and gene copy number variations in northeastern Thais. Immunology 2017, 153, 380–386. [Google Scholar] [CrossRef] [Green Version]
  13. Valiante, N.M.; Uhrberg, M.; Shilling, H.G.; Lienert-Weidenbach, K.; Arnett, K.L.; D’Andrea, A.; Phillips, J.H.; Lanier, L.L.; Parham, P. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 1997, 7, 739–751. [Google Scholar] [CrossRef] [Green Version]
  14. Faure, M.; Long, E.O. KIR2DL4 (CD158d), an NK Cell-Activating Receptor with Inhibitory Potential. J. Immunol. 2002, 168, 6208–6214. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Li, C.; Houser, B.L.; Nicotra, M.L.; Strominger, J.L. HLA-G homodimer-induced cytokine secretion through HLA-G receptors on human decidual macrophages and natural killer cells. Proc. Natl. Acad. Sci. USA 2009, 106, 5767–5772. [Google Scholar] [CrossRef] [Green Version]
  16. Lefebvre, S.; Antoine, M.; Uzan, S.; McMaster, M.; Dausset, J.; Carosella, E.D.; Paul, P. Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer. J. Pathol. 2002, 196, 266–274. [Google Scholar] [CrossRef] [PubMed]
  17. Crisa, L.; McMaster, M.T.; Ishii, J.K.; Fisher, S.J.; Salomon, D.R. Identification of a Thymic Epithelial Cell Subset Sharing Expression of the Class Ib HLA-G Molecule with Fetal Trophoblasts. J. Exp. Med. 1997, 186, 289–298. [Google Scholar] [CrossRef] [Green Version]
  18. Jones, D.C.; Hiby, S.E.; Moffett, A.; Trowsdale, J.; Young, N.T. Nature of allelic sequence polymorphism at the KIR3DL3 locus. Immunogenetics 2006, 58, 614–627. [Google Scholar] [CrossRef]
  19. Trundley, A.E.; Hiby, S.E.; Chang, C.; Sharkey, A.M.; Santourlidis, S.; Uhrberg, M.; Trowsdale, J.; Moffett, A. Molecular characterization of KIR3DL3. Immunogenetics 2006, 57, 904–916. [Google Scholar] [CrossRef]
  20. IPD-KIR Database. Available online: https://www.ebi.ac.uk/ipd/kir/ (accessed on 20 June 2020).
  21. Clustal Omega: Multiple Sequence Alignment. Available online: https://www.ebi.ac.uk/Tools/msa/clustalo/ (accessed on 20 June 2020).
  22. Tajik, N.; Shahsavar, F.; Mousavi, T.; Radjabzadeh, M.F. Distribution of KIRgenes in the Iranian population. Tissue Antigens 2009, 74, 22–31. [Google Scholar] [CrossRef]
  23. Godornes, C.; Leader, B.T.; Molini, B.J.; Centurion-Lara, A.; Lukehart, S.A. Quantitation of rabbit cytokine mRNA by real-time RT-PCR. Cytokine 2007, 38, 1–7. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Brooks, C.R.; Elliott, T.; Parham, P.; Khakoo, S.I. The Inhibitory Receptor NKG2A Determines Lysis of Vaccinia Virus-Infected Autologous Targets by NK Cells. J. Immunol. 2006, 176, 1141–1147. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Jayaraman, J.; Kirgizova, V.; Di, D.; Johnson, C.; Jiang, W.; Traherne, J.A. qKAT: Quantitative Semi-automated Typing of Killer-cell Immunoglobulin-like Receptor Genes. J. Vis. Exp. 2019, 145, 1–19. [Google Scholar] [CrossRef] [PubMed]
  26. Radonic, A.; Thulke, S.; Mackay, I.M.; Landt, O.; Siegert, W.; Nitsche, A. Guideline to reference gene selection for quantitative real-time PCR. Biochem. Biophys. Res. Commun. 2004, 313, 856–862. [Google Scholar] [CrossRef]
  27. Rajagopalan, S.; Long, E.O. A Human Histocompatibility Leukocyte Antigen (HLA)-G–specific Receptor Expressed on All Natural Killer Cells. J. Exp. Med. 1999, 189, 1093–1100. [Google Scholar] [CrossRef] [Green Version]
  28. Rajalingam, R.; Hong, M.; Adams, E.J.; Shum, B.P.; Guethlein, L.A.; Parham, P. Short KIR Haplotypes in Pygmy Chimpanzee (Bonobo) Resemble the Conserved Framework of Diverse Human KIR Haplotypes. J. Exp. Med. 2001, 193, 135–146. [Google Scholar] [CrossRef] [Green Version]
  29. Goodridge, J.P.; Lathbury, L.J.; Steiner, N.K.; Shulse, C.N.; Pullikotil, P.; Seidah, N.G.; Hurley, C.K.; Christiansen, F.T.; Witt, C.S. Three common alleles of KIR2DL4 (CD158d) encode constitutively expressed, inducible and secreted receptors in NK cells. Eur. J. Immunol. 2007, 37, 199–211. [Google Scholar] [CrossRef]
  30. Kikuchi-Maki, A.; Yusa, S.-I.; Catina, T.L.; Campbell, K.S. KIR2DL4 Is an IL-2-Regulated NK Cell Receptor That Exhibits Limited Expression in Humans but Triggers Strong IFN-γ Production. J. Immunol. 2003, 171, 3415–3425. [Google Scholar] [CrossRef]
  31. Takei, Y.; Ueshima, C.; Kataoka, T.; Hirata, M.; Sugimoto, A.; Rokutan-Kurata, M.; Moriyoshi, K.; Ono, K.; Murakami, I.; Iwamoto, S.; et al. Killer cell immunoglobulin-like receptor 2DL4 is expressed in and suppresses the cell growth of Langerhans cell histiocytosis. Oncotarget 2017, 8, 36964–36972. [Google Scholar] [CrossRef] [Green Version]
  32. LeMaoult, J.; Zafaranloo, K.; Le Danff, C.; Carosella, E.D. HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells. FASEB J. 2005, 19, 1–23. [Google Scholar] [CrossRef]
  33. Roe, D.; Vierra-Green, C.; Pyo, C.-W.; Eng, K.; Hall, R.; Kuang, R.; Spellman, S.; Ranade, S.; Geraghty, D.E.; Maiers, M. Revealing complete complex KIR haplotypes phased by long-read sequencing technology. Genes Immun. 2017, 18, 127–134. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. Characterization of the quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) with fluorescent probe assays to detect KIR2DL4, KIR3DL3 and RPII. Left panel shows the scatterplot of the mean cycle time (Ct) for each concentration of the targets, an irrelevant sequence plasmid, RPII and non-target KIR plasmids to evaluate the sensitivity, specificity and reproducibility of primers/probes for (A) KIR2DL4 (C) KIR3DL3 and (E) RPII detections; The right panel shows the plot of Ct against the log of the copy number standards. The multiplex reactions showed comparable efficiencies as the singleplex reactions for (B) KIR2DL4 (D) KIR3DL3 and (F) RPII. The standard curves are shown with the equation of linear regression, a square regression coefficient (R2) and the efficiency (E) for qRT-PCR.
Figure 1. Characterization of the quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) with fluorescent probe assays to detect KIR2DL4, KIR3DL3 and RPII. Left panel shows the scatterplot of the mean cycle time (Ct) for each concentration of the targets, an irrelevant sequence plasmid, RPII and non-target KIR plasmids to evaluate the sensitivity, specificity and reproducibility of primers/probes for (A) KIR2DL4 (C) KIR3DL3 and (E) RPII detections; The right panel shows the plot of Ct against the log of the copy number standards. The multiplex reactions showed comparable efficiencies as the singleplex reactions for (B) KIR2DL4 (D) KIR3DL3 and (F) RPII. The standard curves are shown with the equation of linear regression, a square regression coefficient (R2) and the efficiency (E) for qRT-PCR.
Diagnostics 10 00588 g001
Figure 2. Correlation between the Ct values obtained with singleplex and multiplex qRT-PCR assays. The coefficient of correlation (R2) values for KIR2DL4/3DL3 detections, excluding the outliers marked in gray, were 0.995 and 0.996 for (A) KIR2DL4 and (B) KIR3DL3, respectively. Higher variations of the Ct values were found if gene templates were fewer than 500 copies for the multiplex, the outlier data which was out of limit of detection (LOD).
Figure 2. Correlation between the Ct values obtained with singleplex and multiplex qRT-PCR assays. The coefficient of correlation (R2) values for KIR2DL4/3DL3 detections, excluding the outliers marked in gray, were 0.995 and 0.996 for (A) KIR2DL4 and (B) KIR3DL3, respectively. Higher variations of the Ct values were found if gene templates were fewer than 500 copies for the multiplex, the outlier data which was out of limit of detection (LOD).
Diagnostics 10 00588 g002
Figure 3. ROC analyses of KIR gene and reference gene expressions in 100 healthy donors were shown. (A) ROC curve of the singleplex qRT-PCR showed AUC value for KIR2DL4 and KIR3DL3 were 0.984 and 0.968, respectively (p < 0.001) and for RPII reference was 0.952 (p < 0.002); (B) ROC curve of the multiplex qRT-PCR, AUC value for KIR2DL4 and KIR3DL3 were 0.998 (p < 0.001) and for RPII reference was 0.984 (p < 0.001). ROC—receiver-operating characteristic; AUC—area under the ROC curve.
Figure 3. ROC analyses of KIR gene and reference gene expressions in 100 healthy donors were shown. (A) ROC curve of the singleplex qRT-PCR showed AUC value for KIR2DL4 and KIR3DL3 were 0.984 and 0.968, respectively (p < 0.001) and for RPII reference was 0.952 (p < 0.002); (B) ROC curve of the multiplex qRT-PCR, AUC value for KIR2DL4 and KIR3DL3 were 0.998 (p < 0.001) and for RPII reference was 0.984 (p < 0.001). ROC—receiver-operating characteristic; AUC—area under the ROC curve.
Diagnostics 10 00588 g003
Table 1. Primer and probe sequences used in this study.
Table 1. Primer and probe sequences used in this study.
Probe5′ Fluorophore–Sequence–Quencher 3′Position (Exon)Product Size (bp)Reference
Specific probes for quantitative real–time RT–PCR
P-2DL4FAM–TGGGTTTAACATCTTCACGCTGTAC–BHQ189–113 (E3) This study
P-3DL3TexasRed–TGCGGGTTCCCAGGTCAACTATTCCATGG–BHQ2164–193 (E4) This study
P-RPIITET–TGCTGGACCCACCGGCATGTTCTTTGG–BHQ1180–187 (E26),1–19 (E27) This study
PrimerPrimer sequences 5′–3′
Specific primers for quantitative real-time RT–PCR
2DL4F: TCAGGACAAGCCCTTCTGC5–23 (E3)130[20]
R: GACAGGGACCCCATCTTTC116–134 (E3)
3DL3F: GCAATGTTGGTCAGATGTCAG71–91 (E4)199[20]
R: AGCCGACAACTCATAGGGTA250–269 (E4)
RPIIF: AGTATGGCATGGAGATCCCC137–156 (E26)143This study
R: ATAGGCAGGGGTTGCACC75–92 (E27)
Table 2. Area under the ROC curve analysis of killer-cell immunoglobulin-like receptors (KIR) gene expressions in healthy donors.
Table 2. Area under the ROC curve analysis of killer-cell immunoglobulin-like receptors (KIR) gene expressions in healthy donors.
GenesAUC (95% CI)SEp-Value
Singleplex qRT–PCR
KIR2DL40.984 (0.945, 1.000)0.0200.001
KIR3DL30.968 (0.903, 1.000)0.0330.001
RPII (reference gene)0.952 (0.876, 1.000)0.0390.002
Multiplex qRT–PCR
KIR2DL40.998 (0.994, 1.000)0.002<0.001
KIR3DL30.998 (0.992, 1.000)0.003<0.001
RPII (reference gene)0.984 (0.964, 1.000)0.011<0.001
AUC—area under the ROC curve; SE—standard error.
Table 3. Assessment index of the KIR gene expressions in healthy donors based on ROC analysis results.
Table 3. Assessment index of the KIR gene expressions in healthy donors based on ROC analysis results.
GenesSensitivity (%)Specificity (%)+LR−LRYI
Singleplex qRT-PCR
KIR2DL4100.00099.960250.04099.960
KIR3DL3100.00099.960250.04099.960
RPII (reference gene)100.00099.8808.330.12099.880
Multiplex qRT-PCR
KIR2DL4100.00099.975400.02599.975
KIR3DL3100.00099.975400.02599.975
RPII (reference gene)100.00099.8556.8960.14599.855
+LR—positive likelihood ratio; −LR—negative likelihood ratio; YI—Youden’s index.

Share and Cite

MDPI and ACS Style

Wongfieng, W.; Nutalai, R.; Jumnainsong, A.; Leelayuwat, C. Quantitative Multiplex Real-Time Reverse Transcriptase–Polymerase Chain Reaction with Fluorescent Probe Detection of Killer Immunoglobulin-Like Receptors, KIR2DL4/3DL3. Diagnostics 2020, 10, 588. https://doi.org/10.3390/diagnostics10080588

AMA Style

Wongfieng W, Nutalai R, Jumnainsong A, Leelayuwat C. Quantitative Multiplex Real-Time Reverse Transcriptase–Polymerase Chain Reaction with Fluorescent Probe Detection of Killer Immunoglobulin-Like Receptors, KIR2DL4/3DL3. Diagnostics. 2020; 10(8):588. https://doi.org/10.3390/diagnostics10080588

Chicago/Turabian Style

Wongfieng, Wipaporn, Rungtiwa Nutalai, Amonrat Jumnainsong, and Chanvit Leelayuwat. 2020. "Quantitative Multiplex Real-Time Reverse Transcriptase–Polymerase Chain Reaction with Fluorescent Probe Detection of Killer Immunoglobulin-Like Receptors, KIR2DL4/3DL3" Diagnostics 10, no. 8: 588. https://doi.org/10.3390/diagnostics10080588

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop